Vitrafy Life Sciences in bookbuild for $117.5m float
BALLARAT: Ballarat-based Vitrafy Life Sciences, a biomedical cryopreservation crawling with ex Virtus Health ... read more
Cochlear can maintain rev growth for longer say Citi anaylsts
MELBOURNE: Analysts at Citi have upgraded their rating on hearing implants giant Cochlear ... read more
Treasury Wine guidance reiteration positive claims Citi analysts
MELBOURNE: Treasury Wine Estates’ reiteration of FY25 EBITS guidance of $780-$810 million is ... read more
